| Objective: Clinical research, verify Qianlongtong Cure pass before clinical efficacy suppository on urodynamics in patients with benign prostatic hyperplasia impact.Methods: A randomized clinical control, a total of 60 cases of patients, after typing randomly divided into control group and treatment group, 30 cases of each group, the treatment group to pre-embolization anal longtong Cure pass, the control group at the same time be the forefront of Qianliebiert Cure closed Seoul anal embolism. Are in January for treatment after a course of treatment the overall clinical efficacy were observed, voiding symptom score, maximum flow rate, residual urine volume, prostate volume target, such as urodynamic changes. Compared between the two groups selected, the clinical efficacy after one course of treatment and observation of the target Change.Results: The selected when no significant difference between the two groups, 60 cases of patients evaluated the overall clinical effect of treatment group, voiding symptom score, maximum flow rate, residual urine volume target, such as urodynamics are well in control group, two groups of prostate volume were no significant improvement. No adverse reactions were the treatment group the total effective rate was significantly better than the control group.Qianlongtong Cure suppository before conclusions can effectively pass the good urodynamics prostatic hyperplasia target, and the safe, effective, patients with better compliance.
|
PDF Full Text Request